Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2020-12-08 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于公司竞拍获得国有土地使用权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by SanNuo Biological Sensor Co., Ltd. regarding the company's successful bid to acquire state-owned land use rights. It details the transaction overview, parties involved, land specifics, purpose, and impact on the company. The document is relatively short (1502 characters) and focuses on a specific capital transaction rather than financial results or management changes. It does not contain financial statements or detailed financial analysis. The content aligns with updates on company fundraising or capital structure changes, specifically acquisition of land assets. Therefore, the document fits best under Capital/Financing Update (CAP).
2020-12-08 Chinese
关于向不特定对象发行可转换公司债券申请获得中国证监会同意注册批复的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from the company SanNuo Biological Sensor Co., Ltd. regarding the approval from the China Securities Regulatory Commission (CSRC) for the company's application to issue convertible bonds to unspecified investors. It includes details about the registration approval, validity period, and compliance requirements. The document is short (687 characters) and serves as a formal notice of regulatory approval for a financing activity rather than a detailed financial report or full issuance prospectus. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2020-11-17 Chinese
关于控股股东、实际控制人减持股份超过1%暨减持进展的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the reduction of shareholding by the controlling shareholder and actual controller of the company, including details of the share reduction plan, progress, and compliance with relevant securities laws and regulations. It includes specific data on shares reduced, dates, and percentages, but it is not a financial report, earnings release, or management discussion. It is a regulatory disclosure about insider share transactions exceeding 1%, which fits the category of Major Shareholding Notification (MRQ). The document length is 3529 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the appropriate classification is MRQ.
2020-10-21 Chinese
第四届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of the company regarding the review and approval of the company's 2020 third quarter report. It states that the Supervisory Board has reviewed the Q3 report and confirms its compliance and accuracy, but does not contain the actual financial statements or detailed financial data itself. The document is short (829 characters) and refers readers to the full report published on the official disclosure website. This fits the pattern of a Regulatory Filing (RNS) as it is an announcement about the report rather than the report itself.
2020-10-16 Chinese
2020年第三季度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (567 characters) indicating that the company's 2020 third quarter report has been disclosed on an official regulatory website. It states the report was approved by the board and is available for investors to review. The text does not contain the actual financial data or detailed report content but serves as a notification of the report's publication. According to the 'MENU VS MEAL' rule, such a brief notice that points to the report being available elsewhere is classified as a Report Publication Announcement (RPA).
2020-10-16 Chinese
关于参股子公司深圳市心诺健康产业投资有限公司全资子公司Trividia Health Inc.收到仲裁裁决书的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement from a company about receiving an arbitration award from the International Chamber of Commerce International Court of Arbitration regarding a dispute involving its subsidiary. It details the arbitration case, parties involved, the arbitration decision, and its potential impact on the company's profits. There are no financial statements or detailed financial performance data presented. The document is a legal proceeding update rather than a full audit report or annual/interim report. It fits the category of Legal Proceedings Report (LTR) as it provides information on a significant arbitration outcome affecting the company.
2020-10-16 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.